Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third-generation P2Y 12 inhibitors.
Gjin NdrepepaSalvatore CasseseErion XhepaMichael JonerHendrik B SagerSebastian KufnerKarl-Ludwig LaugwitzHeribert SchunkertAdnan KastratiPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2023)
receptor inhibitors, CNR was associated with a higher risk of adverse outcomes at 1 year.
Keyphrases
- acute myocardial infarction
- percutaneous coronary intervention
- coronary artery disease
- st segment elevation myocardial infarction
- acute coronary syndrome
- st elevation myocardial infarction
- antiplatelet therapy
- coronary artery bypass grafting
- coronary artery
- left ventricular
- emergency department
- heart failure
- aortic stenosis
- binding protein
- aortic valve